In human breast cancer, loss of p120 is observed in approximately 15–20 % of invasive ductal carcinomas, with a marked complete loss of p120 expression in metaplastic breast cancer [17, 23, 27–29]. This evidence concerns the gene CTNND1 and breast carcinoma.